Description
PYLARIFY PIFLUFOLASTAT F18
First action · last action
2021-10-01 · 2022-12-08
Transactions
3
First transaction's obligation
$314,640
Base + all options value (sum of deltas)
$453,129
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25221D0064
NAICS
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-01+$314,640= $314,640
- Mod P000012022-04-15+$237,728= $552,368
- Mod P000022022-12-08-$99,239= $453,129
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-01 | +$314,640 | $314,640 | PYLARIFY PIFLUFOLASTAT F18 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2022-04-15 | +$237,728 | $552,368 | PYLARIFY PIFLUFOLASTAT F18 |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2022-12-08 | −$99,239 | $453,129 | PYLARIFY PIFLUFOLASTAT F18 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JV1AHJHGUGG3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0392 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $357,066 | FY2026 |
| 36C25526N0245 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,172,834 | FY2026 |
| 36C24226N0463 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $624,017 | FY2026 |
| 36C24226N0388 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $830,796 | FY2026 |
| 36C24226D0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25026P0310 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $347,000 | FY2026 |
Other recipients under 6505 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226N0549 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $170 | FY2026 |
| 36C25226N0550 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,500 | FY2026 |
| 36C25226N0551 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,100 | FY2026 |
| 36C25226N0548 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $10,000 | FY2026 |
| 36C25226N0450 | BOSTON SCIENTIFIC CORP | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $607,804 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25222N0050_3600_36C25221D0064_3600 · retrieved 2026-09-26.